Mucosal melanoma
MONDO:0000544A melanoma that arises from a mucosal site.
Also known as: mucosal melanoma
1480 clinical trials for this condition and its sub-types, 47 tagged with Mucosal melanoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Mucosal melanoma
-
Cervix melanoma 1 trial
-
Vaginal melanoma 1 trial
-
Radioactive drug targets Hard-to-Treat melanoma in early trial
Disease control Stopped earlyThis early-stage trial tests a radioactive drug called [225Ac]Ac-A9-3408 in 50 adults with melanoma that has spread or can't be removed by surgery. The main goals are to find a safe dose and check for side effects. Participants receive the drug every 6 weeks for up to 6 doses, an…
Phase 1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can an immune checkpoint blocker outperform interferon in keeping mucosal melanoma at bay?
Disease control Stopped earlyThis phase II trial tests whether toripalimab, an anti-PD-1 antibody, can prevent mucosal melanoma from returning after surgical removal better than high-dose interferon. Adults aged 18 to 75 whose melanoma was completely removed and who have not had prior adjuvant therapy are el…
Phase 2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Engineered virus takes on Hard-to-Treat melanoma
Disease control Stopped earlyThis early-stage trial tested a modified virus (VSV-IFNbetaTYRP1) in 12 patients with advanced melanoma that had spread or could not be removed by surgery. The virus was designed to infect and kill melanoma cells while also boosting the immune system's attack. The main goals were…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental combo therapy for brain metastases shows early safety signals
Symptom relief Stopped earlyThis early-stage trial tested whether adding a device that creates electric fields (NovoTTF-200M) to standard radiation and immunotherapy is safe for people with melanoma that has spread to the brain. Only one person took part before the study was stopped early. The main goal was…
Phase 1 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC